{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T09:02:18Z","timestamp":1785229338788,"version":"3.55.0"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["New Microbes and New Infections"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.nmni.2026.101804","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:41:49Z","timestamp":1782517309000},"page":"101804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Synergistic potential of probiotics and bacteriophages in combating multidrug-resistant microbial infections: A novel therapeutic strategy for the post-antibiotic era"],"prefix":"10.1016","volume":"72","author":[{"given":"Sadaf","family":"Ataei-Alamdari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Alimardani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1110-6447","authenticated-orcid":false,"given":"Hamed","family":"Afkhami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba","family":"Kashfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hasan","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10459","key":"10.1016\/j.nmni.2026.101804_bib1","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050","volume":"404","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.nmni.2026.101804_bib2","first-page":"1","article-title":"Drug-resistant infections: a threat to our economic future","volume":"2","author":"Jonas","year":"2017","journal-title":"World Bank Rep"},{"key":"10.1016\/j.nmni.2026.101804_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1469-0691.2006.01528.x","article-title":"Impact of antibiotic restrictions: the pharmaceutical perspective","volume":"12","author":"Power","year":"2006","journal-title":"Clin Microbiol Infection"},{"issue":"5","key":"10.1016\/j.nmni.2026.101804_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41579-019-0288-0","article-title":"The global preclinical antibacterial pipeline","volume":"18","author":"Theuretzbacher","year":"2020","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"10.1016\/j.nmni.2026.101804_bib5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.nmni.2026.101804_bib6","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jmii.2016.12.009","article-title":"Impact of broad-spectrum antimicrobial treatment on the ecology of intestinal flora","volume":"51","author":"Yang","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.nmni.2026.101804_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/17562848221134396","article-title":"The role of the gut microbiome in colonization resistance and recurrent Clostridioides difficile infection","volume":"15","author":"Seekatz","year":"2022","journal-title":"Therapeut Adv Gastroenterol"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib8","first-page":"2024","article-title":"Alternative approaches to managing microbial susceptibility in a post-antibiotic era","volume":"8","author":"Burciu","year":"2024","journal-title":"Journal of Microbiology and Pathology"},{"key":"10.1016\/j.nmni.2026.101804_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2025.1493915","article-title":"Beyond antibiotics: exploring multifaceted approaches to combat bacterial resistance in the modern era: a comprehensive review","volume":"15","author":"Yarahmadi","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"10.1016\/j.nmni.2026.101804_bib10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4161\/bact.20757","article-title":"The strange history of phage therapy","volume":"2","author":"Summers","year":"2012","journal-title":"Bacteriophage"},{"issue":"8","key":"10.1016\/j.nmni.2026.101804_bib11","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"Expert consensus document. The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12879-018-3028-6","article-title":"Effect of Lactobacillus rhamnosus HN001 on carriage of staphylococcus aureus: results of the impact of probiotics for reducing infections in veterans (IMPROVE) study","volume":"18","author":"Eggers","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib13","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1038\/s41598-018-23437-9","article-title":"Lactobacillus paracasei CNCM I-3689 reduces vancomycin-resistant enterococcus persistence and promotes bacteroidetes resilience in the gut following antibiotic challenge","volume":"8","author":"Crouzet","year":"2018","journal-title":"Sci Rep"},{"issue":"18","key":"10.1016\/j.nmni.2026.101804_bib14","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1128\/AEM.00861-14","article-title":"Lactobacillus rhamnosus GG inhibits the toxic effects of Staphylococcus aureus on epidermal keratinocytes","volume":"80","author":"Mohammedsaeed","year":"2014","journal-title":"Appl Environ Microbiol"},{"issue":"10","key":"10.1016\/j.nmni.2026.101804_bib15","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.3390\/microorganisms11102393","article-title":"Probiotics and their bioproducts: a promising approach for targeting methicillin-resistant staphylococcus aureus and vancomycin-resistant enterococcus","volume":"11","author":"Jain","year":"2023","journal-title":"Microorganisms"},{"issue":"7728","key":"10.1016\/j.nmni.2026.101804_bib16","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41586-018-0616-y","article-title":"Pathogen elimination by probiotic bacillus via signalling interference","volume":"562","author":"Piewngam","year":"2018","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.nmni.2026.101804_bib17","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/nbt.3043","article-title":"Exploiting CRISPR-cas nucleases to produce sequence-specific antimicrobials","volume":"32","author":"Bikard","year":"2014","journal-title":"Nat Biotechnol"},{"issue":"6","key":"10.1016\/j.nmni.2026.101804_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/foods11060785","article-title":"Lacticaseibacillus rhamnosus: a suitable candidate for the construction of novel bioengineered probiotic strains for targeted pathogen control","volume":"11","author":"Mathipa-Mdakane","year":"2022","journal-title":"Foods"},{"key":"10.1016\/j.nmni.2026.101804_bib19","article-title":"Harnessing the human gut microbiota: an emerging frontier in combatting multidrug-resistant bacteria","volume":"16","author":"Ding","year":"2025","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.nmni.2026.101804_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00066-18","article-title":"Phage therapy in the postantibiotic era","volume":"32","author":"Gordillo Altamirano","year":"2019","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.nmni.2026.101804_bib21","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1128\/AAC.01774-15","article-title":"Bacteriophage combinations significantly reduce Clostridium difficile growth in vitro and proliferation in vivo","volume":"60","author":"Nale","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"51","key":"10.1016\/j.nmni.2026.101804_bib22","article-title":"Biofilm-inspired encapsulation of probiotics for the treatment of complex infections","volume":"30","author":"Li","year":"2018","journal-title":"Adv Mater"},{"issue":"2","key":"10.1016\/j.nmni.2026.101804_bib23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3390\/microorganisms14020344","article-title":"Beyond antibiotics: therapeutic strategies utilizing probiotics and bacteriophages against drug-resistant Staphylococcus aureus","volume":"14","author":"Zhao","year":"2026","journal-title":"Microorganisms"},{"issue":"12","key":"10.1016\/j.nmni.2026.101804_bib24","doi-asserted-by":"crossref","first-page":"8062","DOI":"10.15419\/35b1xn36","article-title":"Insights into microbiome-based therapeutics: engineered probiotics, bacteriophages, and microbiome-derived metabolites","volume":"12","author":"Yahya","year":"2025","journal-title":"Biomedical Research and Therapy"},{"issue":"7","key":"10.1016\/j.nmni.2026.101804_bib25","doi-asserted-by":"crossref","DOI":"10.1099\/mic.0.001352","article-title":"Decolonizing drug-resistant E. coli with phage and probiotics: breaking the frequency-dependent dominance of residents","volume":"169","author":"Forsyth","year":"2023","journal-title":"Microbiology"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41385-018-0053-0","article-title":"Interbacterial mechanisms of colonization resistance and the strategies pathogens use to overcome them","volume":"12","author":"Sorbara","year":"2019","journal-title":"Mucosal Immunol"},{"issue":"4","key":"10.1016\/j.nmni.2026.101804_bib27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3390\/nu8040202","article-title":"The intestinal microbiota in metabolic disease","volume":"8","author":"Woting","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.nmni.2026.101804_bib28","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.3389\/fmicb.2019.02305","article-title":"Microbial metabolic capacity for intestinal folate production and modulation of host folate receptors","volume":"10","author":"Engevik","year":"2019","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib29","doi-asserted-by":"crossref","first-page":"fuaa039","DOI":"10.1093\/femsre\/fuaa039","article-title":"Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations","volume":"45","author":"Soltani","year":"2021","journal-title":"FEMS Microbiol Rev"},{"issue":"9","key":"10.1016\/j.nmni.2026.101804_bib30","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1038\/nutd.2013.28","article-title":"Lactobacillus reuteri and Escherichia coli in the human gut microbiota may predict weight gain associated with vancomycin treatment","volume":"3","author":"Million","year":"2013","journal-title":"Nutr Diabetes"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/1462-2920.13589","article-title":"Formation of propionate and butyrate by the human colonic microbiota","volume":"19","author":"Louis","year":"2017","journal-title":"Environ Microbiol"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jcmgh.2020.08.002","article-title":"Human-derived Bifidobacterium dentium modulates the mammalian serotonergic system and gut-brain axis","volume":"11","author":"Engevik","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.nmni.2026.101804_bib33","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/MOG.0b013e32834baa4d","article-title":"Probiotics and immune health","volume":"27","author":"Yan","year":"2011","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.nmni.2026.101804_bib34","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3389\/fphys.2018.00477","article-title":"Role of ROS and nutritional antioxidants in human diseases","volume":"9","author":"Liu","year":"2018","journal-title":"Front Physiol"},{"issue":"7","key":"10.1016\/j.nmni.2026.101804_bib35","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1080\/10408398.2011.619671","article-title":"Immune system stimulation by probiotic microorganisms","volume":"54","author":"Ashraf","year":"2014","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cell.2022.11.017","article-title":"Phage therapy: from biological mechanisms to future directions","volume":"186","author":"Strathdee","year":"2023","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.nmni.2026.101804_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00066-18","article-title":"Phage therapy in the postantibiotic era","volume":"32","author":"Gordillo Altamirano","year":"2019","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib38","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1038\/s41467-023-39028-w","article-title":"Bacteriophage targeting microbiota alleviates non-alcoholic fatty liver disease induced by high alcohol-producing Klebsiella pneumoniae","volume":"14","author":"Gan","year":"2023","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.nmni.2026.101804_bib39","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1002\/med.21572","article-title":"Phage therapy: what factors shape phage pharmacokinetics and bioavailability? Systematic and critical review","volume":"39","author":"D\u0105browska","year":"2019","journal-title":"Med Res Rev"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40560-024-00759-7","article-title":"Current status of bacteriophage therapy for severe bacterial infections","volume":"12","author":"Sawa","year":"2024","journal-title":"J Intensiv Care"},{"key":"10.1016\/j.nmni.2026.101804_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1172635","article-title":"Engineering bacteriophages for enhanced host range and efficacy: insights from bacteriophage-bacteria interactions","volume":"14","author":"Jia","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.nmni.2026.101804_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12941-020-00389-5","article-title":"Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review","volume":"19","author":"Chegini","year":"2020","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22042-1","article-title":"Bacteriophage DW-EC with the capability to destruct and inhibit biofilm formed by several pathogenic bacteria","volume":"12","author":"Wiguna","year":"2022","journal-title":"Sci Rep"},{"issue":"27","key":"10.1016\/j.nmni.2026.101804_bib44","doi-asserted-by":"crossref","first-page":"11197","DOI":"10.1073\/pnas.0704624104","article-title":"Dispersing biofilms with engineered enzymatic bacteriophage","volume":"104","author":"Lu","year":"2007","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"10.1016\/j.nmni.2026.101804_bib45","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2217\/fmb.12.97","article-title":"Bacteriophage endolysins as novel antimicrobials","volume":"7","author":"Schmelcher","year":"2012","journal-title":"Future Microbiol"},{"issue":"9","key":"10.1016\/j.nmni.2026.101804_bib46","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.3390\/microorganisms11092222","article-title":"Bacteriophages as potential clinical immune modulators","volume":"11","author":"Souza","year":"2023","journal-title":"Microorganisms"},{"issue":"10","key":"10.1016\/j.nmni.2026.101804_bib47","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.tim.2023.04.008","article-title":"Immunogenicity of bacteriophages","volume":"31","author":"Champagne-Jorgensen","year":"2023","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.nmni.2026.101804_bib48","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-food-053124-111149","article-title":"Functional diversity of probiotic effector molecules: insights into their role in improving gut health","volume":"17","author":"Bai","year":"2026","journal-title":"Annu Rev Food Sci Technol"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13568-018-0536-0","article-title":"Influence of culture media, pH and temperature on growth and bacteriocin production of bacteriocinogenic lactic acid bacteria","volume":"8","author":"Yang","year":"2018","journal-title":"AMB Express"},{"key":"10.1016\/j.nmni.2026.101804_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2026.1766853","article-title":"Postbiotics and phage synergy in precision oral microbiome engineering: systems biology strategies targeting Streptococcus mutans in dental caries","volume":"13","author":"Radhamanalan","year":"2026","journal-title":"Front Mol Biosci"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib51","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11033-024-10163-x","article-title":"Beyond antibiotics: mesenchymal stem cells and bacteriophages-new approaches to combat bacterial resistance in wound infections","volume":"52","author":"Teymouri","year":"2024","journal-title":"Mol Biol Rep"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib52","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12929-022-00806-1","article-title":"Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far","volume":"29","author":"\u0141usiak-Szelachowska","year":"2022","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.nmni.2026.101804_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40168-021-01026-9","article-title":"Assessment of the microbiome during bacteriophage therapy in combination with systemic antibiotics to treat a case of staphylococcal device infection","volume":"9","author":"Mu","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.nmni.2026.101804_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1487641","article-title":"A comprehensive review of probiotics and human health-current prospective and applications","volume":"15","author":"Sarita","year":"2025","journal-title":"Front Microbiol"},{"issue":"4","key":"10.1016\/j.nmni.2026.101804_bib55","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ijos.2014.52","article-title":"Probiotics to counteract biofilm-associated infections: promising and conflicting data","volume":"6","author":"Vuotto","year":"2014","journal-title":"Int J Oral Sci"},{"issue":"10","key":"10.1016\/j.nmni.2026.101804_bib56","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s13205-024-04101-8","article-title":"Phage therapy: a novel approach against multidrug-resistant pathogens","volume":"14","author":"Kapoor","year":"2024","journal-title":"3 Biotech"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib57","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2477816","article-title":"Microbial micronutrient sharing, gut redox balance and keystone taxa as a basis for a new perspective to solutions targeting health from the gut","volume":"17","author":"Steinert","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.nmni.2026.101804_bib58","article-title":"Probiotic phage steering of disease suppressive rhizosphere microbiome","author":"Yang","year":"2026","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41538-023-00245-8","article-title":"Positive and negative aspects of bacteriophages and their immense role in the food chain","volume":"8","author":"Ranveer","year":"2024","journal-title":"npj Sci Food"},{"issue":"12","key":"10.1016\/j.nmni.2026.101804_bib60","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S1473-3099(24)00424-9","article-title":"Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial","volume":"24","author":"Kim","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.nmni.2026.101804_bib61","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2217\/fmb-2022-0107","article-title":"Bacteriophage therapy for escherichia coli-induced urinary tract infection in rats","volume":"18","author":"Bhargava","year":"2023","journal-title":"Future Microbiol"},{"issue":"2","key":"10.1016\/j.nmni.2026.101804_bib62","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3390\/antibiotics4020160","article-title":"Probiotics for the primary and secondary prevention of C. difficile infections: a meta-analysis and systematic review","volume":"4","author":"McFarland","year":"2015","journal-title":"Antibiotics"},{"issue":"12","key":"10.1016\/j.nmni.2026.101804_bib63","article-title":"Probiotics for the prevention of clostridium difficile\u2010associated diarrhea in adults and children","author":"Goldenberg","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nmni.2026.101804_bib64","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3389\/fmicb.2016.01383","article-title":"\u2018Get in early\u2019; biofilm and wax moth (Galleria mellonella) models reveal new insights into the therapeutic potential of Clostridium difficile bacteriophages","volume":"7","author":"Nale","year":"2016","journal-title":"Front Microbiol"},{"issue":"6","key":"10.1016\/j.nmni.2026.101804_bib65","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/v10060288","article-title":"Phage therapy: what have we learned?","volume":"10","author":"G\u00f3rski","year":"2018","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib66","doi-asserted-by":"crossref","DOI":"10.1093\/ismejo\/wraf086","article-title":"Bifidobacterium breve synergizes with Akkermansia muciniphila and Bacteroides ovatus to antagonize Clostridioides difficile","volume":"19","author":"Li","year":"2025","journal-title":"ISME J"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib67","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1038\/s41467-024-48560-2","article-title":"Bacteriophage defends murine gut from Escherichia coli invasion via mucosal adherence","volume":"15","author":"Wu","year":"2024","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.nmni.2026.101804_bib68","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.4315\/0362-028X.JFP-18-587","article-title":"A bacteriophage cocktail eliminates Salmonella Typhimurium from the human colonic microbiome while preserving cytokine signaling and preventing attachment to and invasion of human cells by salmonella in vitro","volume":"82","author":"Moye","year":"2019","journal-title":"J Food Protect"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib69","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s44259-024-00045-4","article-title":"Phage therapy could be key to conquering persistent bacterial lung infections in children","volume":"2","author":"Sithu Shein","year":"2024","journal-title":"npj Antimicrobials and Resistance"},{"issue":"11","key":"10.1016\/j.nmni.2026.101804_bib70","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1093\/jac\/dkx254","article-title":"A randomized controlled trial of probiotics for Clostridium difficile infection in adults (PICO)","volume":"72","author":"Barker","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.nmni.2026.101804_bib71","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00019-20","article-title":"In vivo targeting of Clostridioides difficile using phage-delivered CRISPR-Cas3 antimicrobials","volume":"11","author":"Selle","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.nmni.2026.101804_bib72","series-title":"Seminars in Colon and rectal surgery","article-title":"Phage therapy for Clostridium difficile infection: an alternative to antibiotics?","author":"Sangster","year":"2014"},{"key":"10.1016\/j.nmni.2026.101804_bib73","doi-asserted-by":"crossref","first-page":"wraf086","DOI":"10.1093\/ismejo\/wraf086","article-title":"Bifidobacterium breve synergizes with Akkermansia muciniphila and Bacteroides ovatus to antagonize Clostridioides difficile","author":"Li","year":"2025","journal-title":"ISME J"},{"issue":"12","key":"10.1016\/j.nmni.2026.101804_bib74","article-title":"Probiotics for preventing urinary tract infections in adults and children","author":"Schwenger","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib75","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00404-018-4771-z","article-title":"Study on the effects of an oral lactobacilli and lactoferrin complex in women with intermediate vaginal microbiota","volume":"298","author":"Russo","year":"2018","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"10.1016\/j.nmni.2026.101804_bib76","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00449-23","article-title":"Case commentary: unlocking the potential of bacteriophage to prevent recurrent urinary tract infections after kidney transplantation","volume":"67","author":"Lee","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.nmni.2026.101804_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/nu12082474","article-title":"PHAGE-2 study: supplemental bacteriophages extend Bifidobacterium animalis subsp. lactis BL04 benefits on gut health and microbiota in healthy adults","volume":"12","author":"Grubb","year":"2020","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.nmni.2026.101804_bib78","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3390\/idr16060092","article-title":"Advancing phage therapy: a comprehensive review of the safety, efficacy, and future prospects for the targeted treatment of bacterial infections","volume":"16","author":"Palma","year":"2024","journal-title":"Infect Dis Rep"},{"issue":"6","key":"10.1016\/j.nmni.2026.101804_bib79","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1111\/iwj.13451","article-title":"The role of topical probiotics on wound healing: a review of animal and human studies","volume":"17","author":"Knackstedt","year":"2020","journal-title":"Int Wound J"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib80","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1473-3099(18)30482-1","article-title":"Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1\/2 trial","volume":"19","author":"Jault","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"28","key":"10.1016\/j.nmni.2026.101804_bib81","doi-asserted-by":"crossref","first-page":"8752","DOI":"10.1021\/acs.nanolett.4c02318","article-title":"Inhalable polymeric microparticles for phage and photothermal synergistic therapy of methicillin-resistant Staphylococcus aureus pneumonia","volume":"24","author":"Liu","year":"2024","journal-title":"Nano Lett"},{"issue":"4","key":"10.1016\/j.nmni.2026.101804_bib82","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01462-20","article-title":"Phage-antibiotic synergy is driven by a unique combination of antibacterial mechanism of action and stoichiometry","volume":"11","author":"Gu Liu","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.nmni.2026.101804_bib83","first-page":"1","article-title":"Personalized inhaled bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis","author":"Chan","year":"2025","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.nmni.2026.101804_bib84","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1111\/ajt.15503","article-title":"Early clinical experience of bacteriophage therapy in 3 lung transplant recipients","volume":"19","author":"Aslam","year":"2019","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.nmni.2026.101804_bib85","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","article-title":"Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus","volume":"25","author":"Dedrick","year":"2019","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.nmni.2026.101804_bib86","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.nmni.2026.101804_bib87","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/ajcn\/83.6.1256","article-title":"Probiotic use in clinical practice: what are the risks?","volume":"83","author":"Boyle","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s44259-025-00117-z","article-title":"Re-evaluating what makes a phage unsuitable for therapy","volume":"3","author":"Cook","year":"2025","journal-title":"npj Antimicrobials and Resistance"},{"issue":"11","key":"10.1016\/j.nmni.2026.101804_bib89","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3390\/antibiotics10111287","article-title":"Mobile antimicrobial resistance genes in probiotics","volume":"10","author":"T\u00f3th","year":"2021","journal-title":"Antibiotics"},{"issue":"4","key":"10.1016\/j.nmni.2026.101804_bib90","doi-asserted-by":"crossref","DOI":"10.1128\/MMBR.00012-19","article-title":"Pharmacologically aware phage therapy: pharmacodynamic and pharmacokinetic obstacles to phage antibacterial action in animal and human bodies","volume":"83","author":"D\u0105browska","year":"2019","journal-title":"Microbiol Mol Biol Rev"},{"issue":"4","key":"10.1016\/j.nmni.2026.101804_bib91","doi-asserted-by":"crossref","first-page":"240","DOI":"10.7326\/M18-0343","article-title":"Harms reporting in randomized controlled trials of interventions aimed at modifying microbiota: a systematic review","volume":"169","author":"Bafeta","year":"2018","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.nmni.2026.101804_bib92","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3390\/antibiotics14030296","article-title":"Metagenomics as a transformative tool for antibiotic resistance surveillance: highlighting the impact of mobile genetic elements with a focus on the complex role of phages","volume":"14","author":"Olsen","year":"2025","journal-title":"Antibiotics"},{"issue":"18","key":"10.1016\/j.nmni.2026.101804_bib93","doi-asserted-by":"crossref","first-page":"9146","DOI":"10.3390\/ijms26189146","article-title":"Advances in genetic transformation of lactic acid bacteria: overcoming barriers and enhancing plasmid tools","volume":"26","author":"Rozanov","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib94","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12864-021-07539-9","article-title":"Whole-genome analysis of probiotic product isolates reveals the presence of genes related to antimicrobial resistance, virulence factors, and toxic metabolites, posing potential health risks","volume":"22","author":"Wang","year":"2021","journal-title":"BMC Genom"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib95","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/med.21593","article-title":"Phage therapy: current status and perspectives","volume":"40","author":"G\u00f3rski","year":"2020","journal-title":"Med Res Rev"},{"issue":"2","key":"10.1016\/j.nmni.2026.101804_bib96","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/v10020064","article-title":"The magistral phage","volume":"10","author":"Pirnay","year":"2018","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.nmni.2026.101804_bib98","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4161\/gmic.1.3.12127","article-title":"Safety assessment of probiotics for human use","volume":"1","author":"Sanders","year":"2010","journal-title":"Gut Microbes"},{"key":"10.1016\/j.nmni.2026.101804_bib99","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s11095-014-1617-7","article-title":"Quality and safety requirements for sustainable phage therapy products","volume":"32","author":"Pirnay","year":"2015","journal-title":"Pharm Res"},{"issue":"4","key":"10.1016\/j.nmni.2026.101804_bib100","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3390\/v11040343","article-title":"Current state of compassionate phage therapy","volume":"11","author":"McCallin","year":"2019","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib101","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1473-3099(18)30482-1","article-title":"Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1\/2 trial","volume":"19","author":"Jault","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.nmni.2026.101804_bib102","first-page":"1","article-title":"Next-generation probiotics: the spectrum from probiotics to live biotherapeutics","volume":"2","author":"O'Toole","year":"2017","journal-title":"Nat Microbiol"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib103","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jconrel.2012.06.003","article-title":"Microencapsulation of probiotics for gastrointestinal delivery","volume":"162","author":"Cook","year":"2012","journal-title":"J Contr Release"},{"issue":"4","key":"10.1016\/j.nmni.2026.101804_bib104","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3390\/v11040352","article-title":"Phage therapy regulation: from night to dawn","volume":"11","author":"Fauconnier","year":"2019","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.nmni.2026.101804_bib105","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/mabi.201200109","article-title":"Novel biopolymer matrices for microencapsulation of phages: enhanced protection against acidity and protease activity","volume":"12","author":"Dini","year":"2012","journal-title":"Macromol Biosci"},{"key":"10.1016\/j.nmni.2026.101804_bib106","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cis.2017.05.014","article-title":"Formulation, stabilisation and encapsulation of bacteriophage for phage therapy","volume":"249","author":"Malik","year":"2017","journal-title":"Adv Colloid Interface Sci"},{"issue":"4","key":"10.1016\/j.nmni.2026.101804_bib107","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.tig.2016.01.005","article-title":"Manipulating bacterial communities by in situ microbiome engineering","volume":"32","author":"Sheth","year":"2016","journal-title":"Trends Genet"},{"issue":"3","key":"10.1016\/j.nmni.2026.101804_bib108","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1128\/MMBR.00069-15","article-title":"Genetically engineered phages: a review of advances over the last decade","volume":"80","author":"Pires","year":"2016","journal-title":"Microbiol Mol Biol Rev"},{"issue":"2","key":"10.1016\/j.nmni.2026.101804_bib109","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10381","article-title":"Phage engineering and phage\u2010assisted CRISPR\u2010Cas delivery to combat multidrug\u2010resistant pathogens","volume":"8","author":"Khambhati","year":"2023","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.nmni.2026.101804_bib110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.34133\/bdr.0017","article-title":"CRISPR-Cas-based engineering of probiotics","volume":"5","author":"Liu","year":"2023","journal-title":"BioDesign Research"},{"issue":"6","key":"10.1016\/j.nmni.2026.101804_bib111","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.cell.2018.08.041","article-title":"Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features","volume":"174","author":"Zmora","year":"2018","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.nmni.2026.101804_bib112","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4292\/wjgpt.v8.i3.162","article-title":"Phage therapy: an alternative to antibiotics in the age of multi-drug resistance","volume":"8","author":"Lin","year":"2017","journal-title":"World J Gastrointest Pharmacol Therapeut"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib113","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cels.2015.06.001","article-title":"Programming a human commensal bacterium, Bacteroides thetaiotaomicron, to sense and respond to stimuli in the murine gut microbiota","volume":"1","author":"Mimee","year":"2015","journal-title":"Cell Syst"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib114","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12866-021-02256-5","article-title":"Application of machine learning in bacteriophage research","volume":"21","author":"Nami","year":"2021","journal-title":"BMC Microbiol"},{"issue":"12","key":"10.1016\/j.nmni.2026.101804_bib115","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2313574121","article-title":"Predictive phage therapy for Escherichia coli urinary tract infections: cocktail selection for therapy based on machine learning models","volume":"121","author":"Keith","year":"2024","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.nmni.2026.101804_bib116","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.718774","article-title":"OneHealth approaches contribute towards antimicrobial resistance: malaysian perspective","volume":"12","author":"Mariappan","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.nmni.2026.101804_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.tifs.2025.105119","article-title":"Globalizing the health-promoting potential of fermented foods: a culturomics pathway to probiotics","author":"Fentie","year":"2025","journal-title":"Trends Food Sci Technol"},{"key":"10.1016\/j.nmni.2026.101804_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.tifs.2025.104938","article-title":"Synergizing artificial intelligence and probiotics: a comprehensive review of emerging applications in health promotion and industrial innovation","author":"Han","year":"2025","journal-title":"Trends Food Sci Technol"},{"key":"10.1016\/j.nmni.2026.101804_bib119","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3389\/fmicb.2017.00559","article-title":"Intriguing interaction of bacteriophage-host association: an understanding in the era of omics","volume":"8","author":"Parmar","year":"2017","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.nmni.2026.101804_bib120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41538-023-00199-x","article-title":"\u2018Multi-omics\u2019 data integration: applications in probiotics studies","volume":"7","author":"Kwoji","year":"2023","journal-title":"npj Sci Food"},{"issue":"3","key":"10.1016\/j.nmni.2026.101804_bib121","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.chom.2026.02.002","article-title":"Strain-level genetic heterogeneity and colonization dynamics drive microbiome therapeutic efficacy","volume":"34","author":"Chen","year":"2026","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.nmni.2026.101804_bib122","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fmicb.2016.00068","article-title":"Using \u201comics\u201d and integrated multi-omics approaches to guide probiotic selection to mitigate chytridiomycosis and other emerging infectious diseases","volume":"7","author":"Rebollar","year":"2016","journal-title":"Front Microbiol"}],"container-title":["New Microbes and New Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2052297526001083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2052297526001083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:15:46Z","timestamp":1785226546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2052297526001083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":121,"alternative-id":["S2052297526001083"],"URL":"https:\/\/doi.org\/10.1016\/j.nmni.2026.101804","relation":{},"ISSN":["2052-2975"],"issn-type":[{"value":"2052-2975","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic potential of probiotics and bacteriophages in combating multidrug-resistant microbial infections: A novel therapeutic strategy for the post-antibiotic era","name":"articletitle","label":"Article Title"},{"value":"New Microbes and New Infections","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmni.2026.101804","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101804"}}